Stefan Glombitza
Chief Executive Officer bij FORMYCON AG
Profiel
Stefan Glombitza is currently the Chief Executive Officer at Formycon AG since 2022.
Previously, he worked at Hexal AG as a Manager-Medical Affairs and at Hexal Pharmaforschung GmbH as the Head-Project Management.
Dr. Glombitza holds a doctorate degree from the University of Regensburg.
Actieve functies van Stefan Glombitza
| Bedrijven | Functie | Begin |
|---|---|---|
| FORMYCON AG | Chief Executive Officer | 01-07-2022 |
Eerdere bekende functies van Stefan Glombitza
| Bedrijven | Functie | Einde |
|---|---|---|
| Hexal Pharmaforschung GmbH | Corporate Officer/Principal | - |
Hexal AG
 Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Corporate Officer/Principal | - |
Opleiding van Stefan Glombitza
| University of Regensburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Health Technology |
| Hexal Pharmaforschung GmbH |
